Losing ground: Multidrug-resistant bacteria in solid-organ transplantation

Current Opinion in Infectious Diseases

Volumn 25, Issue 4, 2012, Pages 445-449

  Herati, Ramin S ^a   Blumberg, Emily A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

antibiotics; carbapenemase; Gram negative rod; multidrug resistant; organ transplantation

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CARBAPENEM; CEFTAROLINE; CHLORAMPHENICOL; CLINDAMYCIN; COLISTIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; LINEZOLID; NITROFURANTOIN; QUINOLONE DERIVATIVE; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BURKHOLDERIA CEPACIA; BURKHOLDERIA CEPACIA INFECTION; GEOGRAPHY; GRAFT RECIPIENT; HUMAN; INFECTION RISK; KLEBSIELLA PNEUMONIAE INFECTION; LUNG TRANSPLANTATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; NONHUMAN; ORGAN TRANSPLANTATION; PSEUDOMONAS INFECTION; REVIEW; RISK FACTOR; SOLID ORGAN TRANSPLANTATION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; ORGAN TRANSPLANTATION; RISK FACTORS;

EID: 84863692055     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e328354f192     Document Type: Review

References (50)

1. Zhong L, Men TY, Li H, et al. Multidrug-resistant Gram-negative bacterial infections after liver transplantation-spectrum and risk factors. J Infect 2012; 64:299-310.
2. Shi SH, Kong HS, Jia CK, et al. Risk factors for pneumonia caused by multidrug-resistant Gram-negative bacilli among liver recipients. Clin Transplant 2010; 24:758-765.
3. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357:2601-2614. (Pubitemid 350294226)
4. Fishman JA. Infections in immunocompromised hosts and organ transplant recipients: essentials. Liver Transpl 2011; 17 (Suppl. 3):S34-S37.
5. Linares L, García-Goez JF, Cervera C, et al. Early bacteremia after solid organ transplantation. Transplant Proc 2009; 41:2262-2264.
6. Cervera C, Fernández-Ruiz M, Valledor A, et al. Epidemiology and risk factors for late infection in solid organ transplant recipients. Transpl Infect Dis 2011; 13:598-607.
7. Bert F, Larroque B, Paugam-Burtz C, et al. Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: an analysis of 259 episodes. Liver Transpl 2010; 16:393-401.
8. Gołebiewska J, Debska-S ́ lizień A, Komarnicka J, et al. Urinary tract infections in renal transplant recipients. Transplant Proc 2011; 43:2985-2990.
9. Kawecki D, Pacholczyk M, Łagiewska B, et al. Urinary tract infections in the early posttransplant period after liver transplantation: etiologic agents and their susceptibility. Transplant Proc 2011; 43:3052-3054.
10. Hoyo I, Linares L, Cervera C, et al. Epidemiology of pneumonia in kidney transplantation. Transplant Proc 2010; 42:2938-2940.
11. Lee SO, Kang SH, Abdel-Massih RC, et al. Spectrum of early-onset and lateonset bacteremias after liver transplantation: implications for management. Liver Transpl 2011; 17:733-741.
12. Iida T, Kaido T, Yagi S, et al. Posttransplant bacteremia in adult living donor liver transplant recipients. Liver Transpl 2010; 16:1379-1385.
13. Lease ED, Zaas DW. Complex bacterial infections pre and posttransplant. Semin Respir Crit Care Med 2010; 31:234-242.
14. Kovats Z, Sü tto Z, Murakö zy G, et al. Airway pathogens during the first year after lung transplantation: a single-center experience. Transplant Proc 2011; 43:1290-1291.
15. Kawecki D, Kwiatkowski A, Sawicka-Grzelak A, et al. Urinary tract infections in the early posttransplant period after kidney transplantation: etiologic agents and their susceptibility. Transplant Proc 2011; 43:2991-2993.
16. Florescu DF, Qiu F, West SB, et al. Staphylococcus aureus infections in kidney transplantation: a matched case controlled study. Scand J Infect Dis. 2012. [Epub ahead of print]
17. Martins N, Martins IS, de Freitas WV, et al. Severe infection in a lung transplant recipient caused by donor-transmitted carbapenem-resistant Acinetobacter baumannii. Transpl Infect Dis 2011. [Epub ahead of print]
18. Simkins J, Muggia V. Favorable outcome in a renal transplant recipient with donor-derived infection due to multidrug-resistant Pseudomonas aeruginosa. Transpl Infect Dis 2011. [Epub ahead of print]
19. Centers for Disease Control and Prevention (CDC). Transmission of multidrug-resistant Escherichia coli through kidney transplantation-California and Texas, 2009. MMWR Morb Mortal Wkly Rep 2010; 59:1642-1646.
20. Edathodu J, Alrajhi A, Halim M, Althawadi S. Multirecipient donor-transmitted tuberculosis. Int J Tuberc Lung Dis 2010; 14:1493-1495.
21. Goldberg E, Bishara J, Lev S, et al. Organ transplantation from a donor colonized with a multidrug-resistant organism: a case report. Transpl Infect Dis 2011. [Epub ahead of print]
22. Watkins AC, Vedula GV, Horan J, et al. The deceased organ donor with an 'open abdomen': proceed with caution. Transpl Infect Dis 2012. [Epub ahead of print]
23. Bonde PN, Patel ND, Borja MC, et al. Impact of donor lung organisms on postlung transplant pneumonia. J Heart Lung Transplant 2006; 25:99-105. (Pubitemid 43049671)
24. Yamada K, Yanagihara K, Hara Y, et al. Clinical features of bacteremia caused by methicillin-resistant Staphylococcus aureus in a tertiary hospital. Tohoku J Exp Med 2011; 224:61-67.
25. Florescu DF, McCartney AM, Qiu F, et al. Staphylococcus aureus infections after liver transplantation. Infection 2011. [Epub ahead of print]
26. Takatsuki M, Eguchi S, Yamanouchi K, et al. The outcomes of methicillinresistant Staphylococcus aureus infection after living donor liver transplantation in a Japanese center. J Hepatobiliary Pancreat Sci 2010; 17:839-843.
27. Radunz S, Juntermanns B, Kaiser GM, et al. Efficacy and safety of linezolid in liver transplant patients. Transpl Infect Dis 2011; 13:353-358.
28. Vernadakis S, Saner FH, Rath PM, et al. Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis. Transpl Infect Dis 2009; 11:346-348.
29. Jorgenson MR, DePestel DD, Carver PL. Ceftaroline fosamil: a novel broadspectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Ann Pharmacother 2011; 45:1384-1398.
30. Rodríguez-Baño J, Picó n E, Gijón P, et al. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-betalactamase-producing Escherichia coli. J Clin Microbiol 2010; 48:1726-1731.
31. Qureshi ZA, Paterson DL, Pakstis DL, et al. Risk factors and outcome of extended-spectrum b-lactamase-producing Enterobacter cloacae bloodstream infections. Int J Antimicrob Agents 2011; 37:26-32.
32. Linares L, Cervera C, Hoyo I, et al. Klebsiella pneumoniae infection in solid organ transplant recipients: epidemiology and antibiotic resistance. Transplant Proc 2010; 42:2941-2943.
33. Gona F, Mezzatesta ML, Corona D, et al. Klebsiella pneumoniae ESBL producers responsible for severe UTIs in a renal transplant unit. Infection 2011; 39:83-85.
34. Winters HA, Parbhoo RK, Schafer JJ, Goff DA. Extended-spectrum betalactamase-producing bacterial infections in adult solid organ transplant recipients. Ann Pharmacother 2011; 45:309-316.
35. De Walthoffen SW, Mlynarczyk A, Sawicka-Grzelak A, et al. Strains of Klebsiella pneumoniae producing extended spectrum beta-lactamases, isolated from organ recipients. Transplant Proc 2011; 43:3128-3129.
36. Rodríguez-Baño J, Navarro MD, Retamar P, et al. b-Lactam/b-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum b-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts. Clin Infect Dis 2012; 54:167-174.
37. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011; 53:60-67.
38. Bergamasco MD, Barroso Barbosa M, de Oliveira Garcia D, et al. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation. Transpl Infect Dis 2012; 14:198-205.
39. Sidjabat HE, Silveira FP, Potoski BA, et al. Interspecies spread of Klebsiella pneumoniae carbapenemase gene in a single patient. Clin Infect Dis 2009; 49:1736-1738.
40. Mathers AJ, Cox HL, Bonatti H, et al. Fatal cross infection by carbapenemresistant Klebsiella in two liver transplant recipients. Transpl Infect Dis 2009; 11:257-265.
41. Mlynarczyk G, Kosykowska E, de Walthoffen SW, et al. A threat of the Klebsiella pneumoniae carbapenemase-producing strains among transplant recipients. Transplant Proc 2011; 43:3135-3136.
42. Rodríguez-Avial C, Rodríguez-Avial I, Merino P, Picazo JJ. Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient. Clin Microbiol Infect 2012; 18:61-66.
43. Kassis-Chikhani N, Saliba F, Carbonne A, et al. Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003-2004. Euro Surveill 2010; 15:pii:19713.
44. Grimwood K, Kidd TJ, Tweed M. Successful treatment of cepacia syndrome. J Cyst Fibros 2009; 8:291-293.
45. Bartáková LV, Fila L, Adámek S, et al. Lung transplantation in cystic fibrosis patients in the Czech Republic: initial single-center experience. Transplant Proc 2010; 42:3711-3713.
46. Levine SM, Transplant/Immunology Network of the American College of Chest Physicians. A survey of clinical practice of lung transplantation in North America. Chest 2004; 125:1224-1238.
47. Nash EF, Coonar A, Kremer R, et al. Survival of Burkholderia cepacia sepsis following lung transplantation in recipients with cystic fibrosis. Transpl Infect Dis 2010; 12:551-554.
48. Aris RM, Routh JC, LiPuma JJ, et al. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med 2001; 164:2102-2106. (Pubitemid 34023582)
49. De Soyza A, McDowell A, Archer L, et al. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 2001; 358:1780-1781. (Pubitemid 33153006)
50. Olland A, Falcoz PE, Kessler R, Massard G. Should cystic fibrosis patients infected with Burkholderia cepacia complex be listed for lung transplantation? Interact Cardiovasc Thorac Surg 2011; 13:631-634.